Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 46,155 | 46,926 | 51,810 | 48,475 | 47,656 |
| Cost of Goods | 29,260 | 31,800 | 31,502 | 32,525 | 29,484 |
| Gross Profit | 16,895 | 15,126 | 20,308 | 15,950 | 18,172 |
| Operating Expenses | 38,040 | 33,964 | 35,772 | 36,390 | 36,597 |
| Operating Income | -20,885 | -18,038 | -14,962 | -19,915 | -17,941 |
| Interest Expense | 510 | 0 | 0 | 0 | 0 |
| Other Income | -58 | 605 | -258 | -185 | -873 |
| Pre-tax Income | -21,453 | -17,433 | -15,220 | -20,100 | -18,814 |
| Income Tax | 63 | -582 | 151 | 178 | 112 |
| Net Income Continuous | -21,516 | -16,851 | -15,371 | -20,278 | -18,926 |
| Net Income | $-21,516 | $-16,851 | $-15,371 | $-20,278 | $-18,926 |
| EPS Basic Total Ops | -2,625.00 | -3,525.00 | -3,625.00 | -4,375.00 | -5,625.00 |
| EPS Basic Continuous Ops | -2,612.69 | -2,855.72 | -3,167.19 | -4,356.06 | -5,601.80 |
| EPS Diluted Total Ops | -2,625.00 | -3,525.00 | -3,625.00 | -4,375.00 | -5,625.00 |
| EPS Diluted Continuous Ops | -2,612.69 | -2,855.72 | -3,167.19 | -4,356.06 | -5,601.80 |
| EPS Diluted Before Non-Recurring Items | -2,125.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-19,612 | $-16,835 | $-13,914 | $-19,035 | $-16,917 |